From the doctor's office to the operating room: Keep up with the latest in healthcare here
NewswiseFrom septic shock to sticker shock. Keep up with this ever-growing, changing sector. Below are some of the latest stories on healthcare on Newswise.
From septic shock to sticker shock. Keep up with this ever-growing, changing sector. Below are some of the latest stories on healthcare on Newswise.
The COVID-19 pandemic has transformed the healthcare landscape and presented new challenges for individuals and healthcare providers.
JMIR Publications published "Examining the Use of an Artificial Intelligence Model to Diagnose Influenza: Development and Validation Study" in the Journal of Medical Internet Research, which reported that it may be possible to diagnose influenza infection by applying deep learning to pharyngeal images given that influenza primarily infects the upper respiratory system.
Scientists report using a single-atom-thick nanomaterial to build a device that can simultaneously detect the presence of the viruses that cause COVID-19 and the flu — at much lower levels and much more quickly than conventional tests for either. They will present their results at ACS Spring 2023.
In an effort to improve understanding of pulmonary fibrosis (PF) and interstitial lung disease (ILD), data from the PFF Registry is presenting researchers with opportunities to accelerate understanding of PF and ILD to improve patient outcomes.
A new collaboration between UC Davis Health and Propeller Health will offer personalized treatment for high-risk patients with asthma and chronic obstructive pulmonary disease.
Out-of-pocket spending was particularly high for hospitalizations that happened early in the year, were covered by insurance plans with high cost-sharing requirements and –interestingly – involved healthy children without chronic conditions – according to the study in JAMA Pediatrics.
Tobacco users in Canada are exposed to higher levels of cyanide than smokers in lower-income nations, according to a large-scale population health study from McMaster University.
More than 1 million Californians live near active oil or gas wells, potentially exposing them to drilling-related pollution that can contribute to asthma, preterm births and a variety of other health problems.
A new study reported in JAMA Network Open unveils disparities in Mesothelioma survival, a grant to help construction workers nail quitting smoking, a new AI algorithm that offers insights into deadly cancer, a newly launched Neuroendocrine Tumors Program, a cancer researcher chosen to co-lead Tumor Biology Program and more are in this month’s tip sheet from Sylvester Comprehensive Cancer Center.
A new study finds some patients with early-stage lung cancer who receive a lobectomy do not fare better than patients who have less lung tissue removed.
Researchers have developed a molecule that is, when administered nasally, extremely effective in preventing the disease caused by all known variants of the SARS-CoV-2 virus.
Rutgers New Jersey Medical School will receive $20 million over five years from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to coordinate research being conducted in eight nations on tuberculosis (TB) control and prevention.
Dr. Pani's research has the potential to significantly impact the health and well-being of border communities.
The cystic fibrosis transmembrane conductance regulator has been studied for years but the combined efforts of St. Jude Children’s Research Hospital and Rockefeller University have yielded new insights.
The Pulmonary Fibrosis Foundation’s (PFF) 13th annual Broadway Belts for PFF! has raised over $465,000 and counting. The March 6 sold-out gala event at New York City’s SONY Hall, which was complemented by a virtual live stream, raised funds to fight pulmonary fibrosis (PF), a life-threatening disease that causes progressive scarring in the lungs.
Staphylococcus aureus, Clostridioides difficile, Candida auris, Drug-resistant Shigella. These bacteria not only have difficult names to pronounce, but they are also difficult to fight off. These bacteria may infect humans and animals, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Antimicrobial resistance is an urgent global public health threat.
Today, Yale Medicine physicians use a new form of technology called “robotic bronchoscopy,” which allows them to better reach smaller parts of the lungs. During a robotic bronchoscopy, the doctor uses a controller at a console to operate a robotic arm, which then guides the bronchoscope’s thin, flexible tube through the airways.
In a Phase II trial led by researchers from The University of Texas MD Anderson Cancer Center, adding ipilimumab to a neoadjuvant, or pre-surgical, combination of nivolumab plus platinum-based chemotherapy, resulted in a major pathologic response (MPR) in half of all treated patients with early-stage, resectable non-small cell lung cancer (NSCLC).
It's sleep awareness week, according to the National Sleep Foundation. It’s important to understand how sleep deprivation can impact your health. Most people recognize that if they don’t get enough sleep, their mood and memory will suffer the next day.
A new study represents a first step towards generating highly detailed 3-dimensional maps of lung tumors using genetically engineered mouse models.
The ATS 2023 International Conference Program is now live! Get ready for a series of dynamic scientific programming with presentations covering the basic sciences, research breakthroughs and clinical treatment, as well as spotlighting the next generation of innovators.
UVA Health researchers have identified a potential treatment to prevent severe COVID-19 in patients at great risk.
The lung transplant team at UK HealthCare’s Transplant Center recently celebrated a major milestone, performing the 500th lung transplant since the lung transplant program was founded in 1991.“This is an impressive milestone, and our whole staff — physicians, surgeons, nurse practitioners, nurse coordinators, pharmacists, nutritionists, social workers, therapists and support staff — should be very proud of their success,” said Sravanthi Nandavaram, M.
Hackensack Meridian JFK University Medical Center announced today the appointment of thoracic surgeon Kostantinos Poulikidis, MD, to the leadership team of the new Advanced Lung and Airway Center.
A population data linkage study using anonymised primary and secondary care health records in Swansea University’s SAIL Databank has revealed that in 2020 and 2021, fewer people in Wales were being diagnosed with long-term conditions than expected.
A team of faculty from Wayne State University has discovered new technology that will quickly and easily detect active Mycobacterium tuberculosis (TB) infection antibodies.
The enzyme TBK1 is an important component of the innate immune system that plays a critical role in the defense against viruses. Upon mutation-induced loss of TBK1 function, patients show an increased susceptibility to viral infections.
In a nationwide study, researchers found Black patients are diagnosed with pulmonary fibrosis an average of 10 years earlier than white patients, highlighting the need for updated screening and treatment guidance for the deadly disease.
Mercy Medical Center has announced the opening of the new Motility and Breath Testing Suite, part of an 8,200+ square foot expansion of the hospital’s Endoscopy Center, located on the 2nd floor of Mercy’s renown Mary Catherine Bunting Center.
Adults living with cerebral palsy cannot die from cerebral palsy, yet the condition is commonly listed as an underlying cause of death on records for adults with cerebral palsy. Research from the University of Michigan Health System suggests that mislabeling the cause of death for patients with cerebral palsy can set back appropriate care for individuals with cerebral palsy.
A new class of oral drugs can inhibit a wide range of SARS-CoV-2 variants, researchers report, potentially identifying new antiviral agents providing broad activity against the constantly emerging new strains of the COVID-19 virus
The link between symptoms of COVID-19 and physical inactivity is increasingly evident. An article recently published in the journal Scientific Reports by researchers at the University of São Paulo (USP) in Brazil describes a study in which COVID-19 survivors with at least one persistent symptom of the disease were 57% more likely to be sedentary, and the presence of five or more post-acute sequelae of infection by SARS-CoV-2 increased the odds of physical inactivity by 138%.
A new study led by researchers at Harvard Medical School illuminates how the brain becomes aware that there is an infection in the body.
The same genetics that helped some of our ancestors fight the plague is still likely to be at work in our bodies today, potentially providing some of the population with extra protection against respiratory diseases such as COVID-19. However, there is a trade-off, where this same variation is also linked to increased autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease.
The research team consists of six investigators who will lead three separate project grants and three separate cores, in the hopes of finding new avenues for research and treatments to help patients who suffer from conditions like chronic obstructive pulmonary disorder, pulmonary fibrosis and acute respiratory distress disorder, a common and serious complication of COVID-19.
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system.
Bioengineers from Columbia University are developing a pipeline to systematically evaluate how bacterial treatments might synergize with existing anti-cancer therapies in preclinical models.
Lung cancer patients with moderate to severe depression are 2 to 3 times more likely to have inflammation levels that predict poor survival rates, a new study found. The results may help explain why a substantial portion of lung cancer patients fail to respond to new immunotherapy and targeted treatments that have led to significantly longer survival for many people with the disease.
Patients with serious pneumococcal infections, including pneumonia and sepsis, are at a substantially increased risk of heart attack after the onset of infection.
New insights into the importance of early-life factors on lung health have been unveiled in the most comprehensive study of its kind, led by the Universities of Essex and Bristol.
Despite COPD’s pervasiveness, it is generally assumed that the main instigator in its development is tobacco smoking. The 2023 Global Initiative for Chronic Obstructive Lung Disease or GOLD report is proposing a new definition of COPD, one that acknowledges the key pathogenic role of tobacco smoking but accounts for other factors that also contribute to COPD.
Schools are among the most notable settings people associate with picking up viral infections such as the common cold, various types of the flu or other respiratory viruses.
The Red Tide Respiratory Forecast — www.RedTideForecast.com — is a beach-level risk forecast activated during red tide conditions that tells beachgoers what red tide impacts are expected to be at individual beaches at different times of the day. The Forecast is also available in Spanish at www.PronosticoMareaRoja.com.
Hackensack Meridian Jersey Shore University Medical Center recently celebrated the opening of a new, specialized Pulmonary Hypertension Center.
Vaping cannabidiol (CBD), a compound found in marijuana, leads to more severe lung damage than vaping nicotine, according to a study out of Roswell Park Comprehensive Cancer Center. Until now, research on the health effects of vaping, or using e-cigarettes, has focused almost exclusively on vaping nicotine as opposed to CBD. Previous research has documented the effects of smoking cannabis, but the effects of vaping cannabinoids such as CBD were not previously known.
UC San Francisco researchers have uncovered a surprising role for fibroblasts in the lungs in activating T cell inflammation that drives lung destruction in COPD exacerbation triggered by viral infection. They also identified a T cell subset that can be targeted to treat COPD exacerbations.